NERV · Company research

Minerva Neurosciences, Inc (NERV): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

15records availableHealthcare

Stock News & Events data

Database-backed records only

15 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Minerva Neurosciences Inc. Stock Grades | NERV - Barron'sMinerva Neurosciences Inc. Stock Grades | NERV Barron'sView source ↗Barron'sOct 4, 2026neutral00.6
Minerva Neuroscie (NERV-Q) Stock Price and News - The Globe and MailMinerva Neuroscie (NERV-Q) Stock Price and News The Globe and MailView source ↗The Globe and MailOct 1, 2026neutral00.6
Jefferies upgrades Minerva Neurosciences stock rating on regulatory pathway - Investing.comJefferies upgrades Minerva Neurosciences stock rating on regulatory pathway Investing.comView source ↗Investing.comAug 14, 2026neutral00.6
Minerva Neurosciences (NERV) Gains 1.43% as Stock Tests Resistance at $4.48 - Fundamentals - www.dars.gov.etMinerva Neurosciences (NERV) Gains 1.43% as Stock Tests Resistance at $4.48 - Fundamentals www.dars.gov.etView source ↗www.dars.gov.etJul 18, 2026neutral00.6
Minerva Neurosciences Inc (NERV) Q1 2026 Earnings: Wider Loss Highlights Ongoing Pre-Revenue Development Stage - Annual Report - po-news-eg.netMinerva Neurosciences Inc (NERV) Q1 2026 Earnings: Wider Loss Highlights Ongoing Pre-Revenue Development Stage - Annual Report po-news-eg.netView source ↗po-news-eg.netMay 25, 2026neutral00.6
Should I buy Minerva Neurosciences (NERV) - Zacks Investment ResearchShould I buy Minerva Neurosciences (NERV) Zacks Investment ResearchView source ↗Zacks Investment ResearchMay 20, 2026neutral00.6
NERV Earning Date, Earning Analysis and Earning Prediction - Intellectia AINERV Earning Date, Earning Analysis and Earning Prediction Intellectia AIView source ↗Intellectia AIApr 4, 2026neutral00.6
Minerva Neurosciences Stock (NERV) Opinions on $200M Funding Deal | NERV Stock News - Quiver QuantitativeMinerva Neurosciences Stock (NERV) Opinions on $200M Funding Deal | NERV Stock News Quiver QuantitativeView source ↗Quiver QuantitativeOct 21, 2025neutral00.6
Minerva Neurosciences Stock Hits Near 2-Year High On FDA Pathway, $200M Boost — Retail Sees FDA Catalyst - StocktwitsMinerva Neurosciences Stock Hits Near 2-Year High On FDA Pathway, $200M Boost — Retail Sees FDA Catalyst StocktwitsView source ↗StocktwitsOct 21, 2025neutral00.6
Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Pr - Investing News NetworkMinerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Pr Investing News NetworkView source ↗Investing News NetworkOct 21, 2025neutral00.6
Minerva Neurosciences(NERV) Stock Options Chain | Quotes & News - MoomooMinerva Neurosciences(NERV) Stock Options Chain | Quotes & News MoomooView source ↗MoomooJul 10, 2025neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNMar 27, 2024neutral00.6
NERV Stock Price and Chart — NASDAQ:NERV - TradingViewNERV Stock Price and Chart — NASDAQ:NERV TradingViewView source ↗TradingViewNov 9, 2021neutral00.6
Minerva Neurosciences Stock Price Forecast. Should You Buy NERV? - StockInvest.usMinerva Neurosciences Stock Price Forecast. Should You Buy NERV? StockInvest.usView source ↗StockInvest.usDec 1, 2020neutral00.6
Minerva Neurosciences, Inc. (NERV) Stock Price, News, Quote & History - Yahoo! Finance CanadaMinerva Neurosciences, Inc. (NERV) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaMay 7, 2017neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.